Krebs Biochemicals & Industries Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jitendra Shah

Chief executive officer

₹40.0k

Total compensation

CEO salary percentage	n/a
CEO tenure	less than a year
CEO ownership	0.0005%
Management average tenure	no data
Board average tenure	9yrs

Recent management updates

Recent updates

CEO

Jitendra Shah (55 yo)

less than a year

Tenure

₹40,000

Compensation

Mr. Jitendra Rameshchandra Shah serves as an Executive Director of Krebs Biochemicals & Industries Limited since August 10, 2023 and served its Additional Non-Executive Director of Krebs Biochemicals & Ind...

Board Members

Name	Position	Tenure	Compensation	Ownership
Jitendra Shah	MD, CEO & Director	2.5yrs	₹40.00k	0.00046% ₹ 7.1k
R. Ravi	Non-Executive Chairman	31.6yrs	₹45.00k	0.11% ₹ 1.7m
Gundapaneni Venkata Prasad	Independent Non-Executive Director	19.7yrs	₹90.00k	0.46% ₹ 7.1m
Avinash Ravi	Non-Executive Director	15.3yrs	₹45.00k	9.93% ₹ 152.7m
Pabitra Kumar Bhattacharyya	Non-Executive Director	2.8yrs	₹3.00m	no data
Satish Khivsara	Independent Non-Executive Director	8.8yrs	₹90.00k	0.00023% ₹ 3.5k
Tangirala Malati	Independent Non-Executive Director	9.3yrs	₹65.00k	no data
Raj Kamal Verma	Independent Non-Executive Director	8.3yrs	₹40.00k	0.00093% ₹ 14.3k

9.0yrs

Average Tenure

70yo

Average Age

Experienced Board: KREBSBIO's board of directors are considered experienced (9 years average tenure).

Krebs Biochemicals & Industries Management

Management criteria checks 2/4

Key information

Recent management updates

Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer

Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer

Krebs Biochemicals & Industries Limited, Annual General Meeting, Sep 27, 2023

Krebs Biochemicals & Industries Limited Approves CFO Changes

Krebs Biochemicals & Industries Limited, Annual General Meeting, Sep 30, 2022

Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022

Recent updates

Third quarter 2024 earnings released: ₹2.31 loss per share (vs ₹2.58 loss in 3Q 2023)

Krebs Biochemicals & Industries Limited to Report Q3, 2024 Results on Feb 12, 2024

Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer

Second quarter 2024 earnings released: ₹1.66 loss per share (vs ₹1.88 loss in 2Q 2023)

New minor risk - Share price stability

Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer

Krebs Biochemicals & Industries Limited to Report Q2, 2024 Results on Nov 08, 2023

Krebs Biochemicals & Industries Limited, Annual General Meeting, Sep 27, 2023

First quarter 2024 earnings released: ₹2.47 loss per share (vs ₹3.77 loss in 1Q 2023)

Krebs Biochemicals & Industries Limited to Report Q1, 2024 Results on Aug 09, 2023

Full year 2023 earnings released: ₹11.30 loss per share (vs ₹20.65 loss in FY 2022)

Krebs Biochemicals & Industries Limited to Report Q4, 2023 Results on May 24, 2023

Third quarter 2023 earnings released: ₹2.58 loss per share (vs ₹6.00 loss in 3Q 2022)

Krebs Biochemicals & Industries Limited Approves CFO Changes

Krebs Biochemicals & Industries Limited to Report Q3, 2023 Results on Feb 03, 2023

Second quarter 2023 earnings released: ₹1.88 loss per share (vs ₹5.05 loss in 2Q 2022)

Second quarter 2023 earnings released: ₹1.88 loss per share (vs ₹5.05 loss in 2Q 2022)

Krebs Biochemicals & Industries Limited to Report Q2, 2023 Results on Nov 10, 2022

Krebs Biochemicals & Industries Limited, Annual General Meeting, Sep 30, 2022

First quarter 2023 earnings released: ₹3.77 loss per share (vs ₹4.37 loss in 1Q 2022)

Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022

Krebs Biochemicals & Industries Limited to Report Q1, 2023 Results on Aug 01, 2022

Full year 2022 earnings released: ₹21.21 loss per share (vs ₹14.45 loss in FY 2021)

Krebs Biochemicals & Industries Limited to Report Q4, 2022 Results on May 23, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: ₹5.05 loss per share (vs ₹3.26 loss in 2Q 2021)

Non-Executive Director Manish Jain has left the company

First quarter 2022 earnings released: ₹4.37 loss per share (vs ₹3.43 loss in 1Q 2021)

Full year 2021 earnings released: ₹14.53 loss per share (vs ₹16.04 loss in FY 2020)

Third quarter 2021 earnings released: ₹4.21 loss per share (vs ₹4.60 loss in 3Q 2020)

Krebs Biochemicals & Industries Limited to Report Q3, 2021 Results on Jan 30, 2021

New 90-day high: ₹138

New 90-day high: ₹94.40

Krebs Biochemicals & Industries Limited to Report Q2, 2021 Results on Nov 05, 2020

Krebs Biochemicals & Industries Limited to Report Q1, 2021 Results on Aug 07, 2020

Earnings released

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age